Urgent recall of paracetamol pills over ‘contamination' fears – as patients urged to check packets now
DRUG ALERT Urgent recall of paracetamol pills over 'contamination' fears – as patients urged to check packets now
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
BATCHES of an over-the-counter paracetamol have been recalled over fears some pills could be "contaminated".
The recall notice was issued by the Medicines and Healthcare products Regulatory Agency (MHRA) after a small number of pills were found to be "discoloured".
Sign up for Scottish Sun
newsletter
Sign up
1
The pills have been recalled as a precautionary measure due to contamination following a small number of complaints of discoloured tablets within the pots
Credit: Getty
Two batches of paracetamol 500mg doses made by Chelonia Healthcare Limited come under the recall.
The batch codes to look out for are 2312010 and 2312011, which can be found on the packaging.
Also, the affected batches have an expiry date of the 30th and 31st of November 2027 and were distributed earlier this year.
The alert said: "Patients or carers should check to see if they have received tablets from the listed batches of Paracetamol 500mg Tablets.
"The batch number can be found on the label of the medicine bottle and on the outer carton. These tablets can only be obtained from a pharmacy with a prescription.
"The number of tablets you will have been given will vary depending on your prescription and you may have only received a small number of tablets."
The recall added the pills are white and capsule-shaped, with a score on the side.
And if you find tablets that are discoloured in any way, in pots from the listed batches, you should contact your pharmacist or the healthcare professional who dispensed your prescription.
Patients who may have taken the medication and experience an "adverse reaction" are also urged to seek medical attention.
Furthermore, any suspected adverse reactions should be reported via the MHRA Yellow Card scheme.
Beware 3 of the most dangerous medicines in the world - including one found in almost EVERY home
The recall notice hasn't detailed what risk, if any, there is taking the medication.
But previous cases involving discoloured paracetamol tablets have been linked to fungal contamination.
A similar recall was issued in Europe in 2019 after batches of the medication were found to be contaminated with Penicillium citrinum.
The MHRA has described the recall as Class 2, which means the defect may cause mistreatment or harm to the patient but is not life-threatening or serious.
Chemists have been told to stop supplying the affected batches immediately.
What packets have been recalled?
Paracetamol 500mg Tablets
PL: 33414/0126
Active ingredient: Paracetamol
SNOMED code: 33554711000001108
GTIN: 05060014445506
Affected lot batch numbers
Batch no. 2312010 - expiry date 30/11/27 - 100 tablets (pots) - first distributed 14/4/25
Batch no. 2312011 - expiry date 31/11/27 - 100 tablets (pots) - first distributed 15/5/25
The recall adds: "Quarantine all remaining stock and return it to your supplier's approved process."
Paracetamol is one of the most commonly taken medications in the UK.
It's estimated just under 6,300 tonnes are sold a year.
It's widely available to buy over-the-counter at shops and pharmacies, but you may be able to get it on prescription if you have long-term pain.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
an hour ago
- Scottish Sun
I lost three stone in just 10 weeks on Mounjaro, but suffered with an instant side effect that won't budge
Read on for more side effects of using weight loss jabs NO WEIGH I lost three stone in just 10 weeks on Mounjaro, but suffered with an instant side effect that won't budge Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A WOMAN has revealed that she has lost three stone in just ten weeks thanks to weight loss jabs. Kayleigh Akister, from Lancaster, took to social media to share her weight loss transformation. Sign up for Scottish Sun newsletter Sign up 2 Kayleigh Akister revealed her weigh tloss journey using Mounjaro Credit: Facebook 2 Despite being thrilled with her new weight, there was one side effect she couldn't budge Credit: Facebook She wrote: "After 10 weeks I have lost 3 stone." Taking to social media, she shared images of herself before her weight loss wearing a beige floor-length dress. She revealed that she initially weighed 14.5st and had gone down to 11.5st. But now, Kayleigh looked much smaller and happier as she wore a silky, figure-hugging dress that showed off her new body. While Kayleigh was thrilled by the weight loss, she had experienced one setback. She revealed that since being on the weight loss jab, her hair had become thin and was falling out. Kayleigh added: "But (I) started with hair loss, it feels so thin anyone else have this and what will help please?" Unfortunately, hair loss is listed as a common side effect of Mounjaro. This can be heightened with losing weight at a fast pace. Telogen effluvium is a form of alopecia that is temporary and caused by sudden changes in the body (like weight loss). I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care It causes hair follicles to enter the resting phase and shedding phase of the hair growth cycle. Kayleigh's post was shared to the Facebook group, mounjaro ozempic wegovy weight loss support, and people were quick to share their tips on combatting hair loss on the drug. One person wrote: "Congrats on your success!! Hair loss is common with weight loss, especially a lot of weight loss in a short time. Make sure you're getting your protein, drinking water and taking a multivitamin." Another commented: "My hair is so bad. I don't know how I'm not bald already! I'm doing everything I can to stop the shed but nothing seems to be working!" "You look amazing. I believe losing weight too quickly will cause some hair loss," penned a third. Meanwhile, a fourth said: "I take collagen and biotin and it definitely helps me." "Try taking collagen supplements, they've really strengthened my hair and nails! My skin looks younger too. Been on them 2 months,' claimed a fifth Someone else added: "Bloody hell, well done. 16 weeks and a whopping 1 stone down."
Telegraph
3 hours ago
- Telegraph
World first as life-saving cancer drugs to be mixed at patients' bedsides
Cancer patients will get personalised drugs made at their bedside under new laws, The Telegraph can reveal. The UK is the first country in the world to relax the strict manufacturing rules that cause delays to time-sensitive treatments. An increasing number of new medicines, including for cancer and rare genetic disorders, involve creating a bespoke drug for each patient by collecting their cells and modifying them in a laboratory, before they are injected back into the patient. But because the samples have to be taken and edited in specialist facilities – often hundreds of miles away – patients are too often facing delays. They may become too unwell to receive the drug, or the medicine itself may not survive the journey because of its short shelf-life. From now, the last of these steps can be completed closer to the patient, reducing the time it takes to produce a life-saving treatment from months to just days, the medical regulator said. 'Flexible, responsive system' The new laws, introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), will mean the drugs can be manufactured where the patient is – and given to them in hospital or their own homes. Writing in The Telegraph, Lawrence Tallon, the new chief executive of the MHRA, said it was about creating 'a more flexible, responsive system that meets the needs of modern medicine' rather than forcing 'the medicine to fit an outdated system'. 'Some of these advanced therapies are made using a person's own cells. Others are built around their genetic code. A few are so sensitive they can't be frozen or stored – they have to be given to the patient within mere minutes of being made. That's a world away from how medicines are typically mass-made and distributed today,' he said. 'In these cases, delays can be critical. Some patients have become too unwell to receive their treatment in time. In others, the medicine simply didn't survive the journey.' He added: 'Hospitals can now carry out the final steps of manufacturing on-site – under the same strict standards, but far more quickly. 'That means a cancer patient could now have their immune cells collected, modified, and returned at the same hospital. A child with a rare genetic disorder can receive a therapy made at their bedside.' 'Personalised therapies' Mobile units will also be deployed to finish the manufacturing of the drugs for patients who are too sick to leave their homes or need to limit hospital visits because of weakened immune systems. The MHRA said the move mirrored how chemotherapy and antibiotics are prepared locally, but stressed that there would still be strict safeguards and regulatory protocols. There will also be a 'central control site' that will oversee the personalised therapies being completed in hospitals. Wes Streeting, the Health Secretary, said it was a 'game-changer'. 'Cancer treatments tailored in days, not months. Life-saving therapies made at your bedside, not hundreds of miles away,' he said. 'Our Plan for Change promised to build an NHS fit for the future. Today we're delivering on that pledge by bringing cutting-edge care directly to patients when they need it most. 'This type of therapy means patients can be treated and return home more quickly.' One example of a personalised treatment that is set to become more accessible for patients is CAR-T cancer therapy. It involves genetically modifying a blood cancer patients' immune cells so that the immune system recognises and kills the cancer cells that would otherwise go undetected by the body and continue to spread. Previously, hospitals were only able to offer these treatments through complicated, one-off arrangements. The changes have already come into effect after the legislation, known as The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025, was passed last month. It covers a range of innovations, including cell and gene therapies, tissue-engineered treatments, 3D printed products, blood products, and medicinal gases. Lord Vallance, the science minister and Government's former chief scientific officer, said the 'world-first framework gives the NHS and innovators a clear, safe way to bring advanced treatments from the lab to the patient's bedside'. 'It's a powerful example of how smart regulation can help more patients benefit from the best of British science.' 'Modern medicine needs a modern delivery system' By Lawrence Tallon For most medicines, the system works well enough. Medicines are made in bulk, boxed up, and shipped off to where they're needed in the world. It's how care has been delivered for decades. But a new generation of personalised therapies is beginning to challenge that model – and unless we adapt, patients could miss out. Some of these advanced therapies are made using a person's own cells. Others are built around their genetic code. A few are so sensitive they can't be frozen or stored – they have to be given to the patient within mere minutes of being made. That's a world away from how medicines are typically mass-made and distributed today. In these cases, delays can be critical. Some patients have become too unwell to receive their treatment in time. In others, the medicine simply didn't survive the journey. We need a more flexible, responsive system that meets the needs of modern medicine, not force the medicine to fit an outdated system. That's why this week, the UK became the first country in the world to introduce a new legal framework that allows these advanced medicines to be made at the point of care. Under new regulations introduced by the Medicines and Healthcare products Regulatory Agency (MHRA), hospitals can now carry out the final steps of manufacturing on-site – under the same strict standards, but far more quickly. That means a cancer patient could now have their immune cells collected, modified and returned at the same hospital. A child with a rare genetic disorder can receive a therapy made at their bedside. No more shipping cells hundreds of miles away and hoping they survive the journey back. It also offers a safer alternative for people too unwell to travel, or whose immune systems make hospital visits risky. 'Supporting early access to promising treatments' This is part of a wider effort to modernise the way we support innovation in the UK. We've shortened the time it takes to approve clinical trials to 40 days. We've introduced new routes for authorising medicines already approved by trusted international regulators. And where the evidence is strong and the need is urgent, we support early access to promising treatments. We're paying particular attention to rare diseases, where patients often face the longest waits for new treatments. While each condition may affect only a few people, the overall impact is large: around 3.5 million people in the UK, and an estimated 300 million globally, live with a rare condition. Yet developing treatments is often more difficult, with fewer clinical trial participants and less commercial return. That's why we're offering targeted support. For companies working on rare disease therapies, we've reduced or waived fees and increased access to expert scientific advice. The aim is to make it simpler and more affordable to bring forward safe treatments where there is high need and few other options. We're also supporting smarter ways to generate evidence. For very rare conditions, large-scale trials aren't always possible. We're working with researchers to use high-quality real-world data, like NHS records and patient registries, so that safe and effective treatments aren't held back for lack of traditional trial data. Medical innovation doesn't end with discovery or what's in the vial. It's also about tackling the barriers that stop new treatments reaching patients. That means creating a safe system built for tomorrow's medicines – especially for people with the fewest options – whether by changing how they're approved, how trials are run, or how evidence is gathered. After all, a life-changing treatment only matters because we can deliver it when and where the person needs it.
Scottish Sun
21 hours ago
- Scottish Sun
I've lost 5.5 stone on Mounjaro but still eat chocolate & get takeaways every week – the truth everyone needs to hear
Read on to see why losing weight on fa loss jabs too quickly can be bad WEIGH TO GO! I've lost 5.5 stone on Mounjaro but still eat chocolate & get takeaways every week – the truth everyone needs to hear Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A WOMAN who has lost 5.5 stone on Mounjaro in eight months has shared the advice everyone needs to hear. La Hauser, from the UK, took to social media to share why you shouldn't be losing weight too quickly on the weight loss jab. Sign up for Scottish Sun newsletter Sign up 2 La Hauser shared a warning for those on weight loss jabs Credit: facebook 2 Over eight months, La has lost 5.5 stone and still enjoys a takeaway Credit: facebook La revealed that she was losing 2.7lbs a week on the jab, but was still seeing people online call it a slow loss. But she reckons she has found the key to success on the injection, and it still allows her to eat takeaways. She wrote: "I started in January and have lost an average of 2.7lbs per week. "I've lost 5 and a half stone in total. I still have a few stone to lose to be at the weight of my preference. READ MORE WEIGHT LOSS STORIES WEIGH TO GO! I shed 6st without Mounjaro & had no loose skin - my weight loss hack is free "There are so many posts where people are saying they are disappointed they have only lost 3 pounds and their mate lost 3 stone in the first week." Instead, La said those on their weight loss journey should concentrate on being consistent, rather than how much they are losing. She even revealed that by going for a slower approach, she was still able to enjoy sweet treats and takeaways while shifting the weight. She continued: "Don't compare to others. Focus on your journey. Focus on what makes you feel joy. "I eat a takeaway/restaurant meal every week. I eat chocolate every day, but I track every calorie so I know I'm still focused even when it's an unhealthy option." The less is more approach is obviously more sustainable than depriving yourself of everything, like a crash diet, so you stay consistent even without the drug. "Don't deprive yourself as you're in it for the long haul, make it sustainable, make it enjoyable," she added. The post was shared on the Facebook group, mounjaro ozempic wegovy weight loss support, and was a hit with other members. One person wrote: "I totally agree! Keep up the good work - been on for almost 2 months - lost 16. I'm pleased." Another commented: "Well said and well done." "Great advice," penned a third. What to do if you lose too much weight too quickly whilst on Mounjaro IF you're losing too much weight too quickly while on Mounjaro, it's important to take action to avoid potential health risks like muscle loss, malnutrition, dehydration, and fatigue. Here's what you can do: Evaluate Your Caloric Intake Mounjaro reduces appetite, which can make it easy to eat too little. If you're losing weight too fast (more than two to three lbs per week after the initial adjustment period), try: Tracking your food intake to ensure you're eating enough calories (apps like MyFitnessPal can help). Increasing protein intake to preserve muscle mass (aim for 0.6–1g per pound of body weight). Adding healthy fats and complex carbs (e.g., avocados, nuts, whole grains) for balanced energy. Adjust Your Dosage (With Doctor's Approval) If your weight loss is too rapid or causing side effects, your doctor may: Pause dose increases or lower your dosage. Adjust your treatment plan to stabilise your weight loss. Strength Training & Exercise To prevent muscle loss: Incorporate resistance training at least two to three times per week. Stay active with low-impact exercises like walking or yoga. Hydrate & Manage Electrolytes Drink enough water (Mounjaro can reduce thirst). Electrolytes matter - Consider adding magnesium, sodium, and potassium if you feel weak or fatigued. Monitor for Malnutrition & Deficiencies Rapid weight loss can cause vitamin/mineral deficiencies (especially B12, iron, and electrolytes). If you experience: Fatigue, hair loss, or dizziness, ask your doctor about supplements. Consider Further Medical Guidance If your weight loss is excessive or causing health concerns, speak with your healthcare provider. They might adjust your dosage, diet, or exercise plan to help stabilise your weight loss. Meanwhile a fourth said: "Totally agree." "Well done, looking great,' claimed a fifth Someone else added: "Thank you! I needed to hear this right now!"
